Chemical inhibitors of Gm672 can exert their inhibitory effects through various molecular mechanisms, primarily by targeting the kinases that are responsible for the phosphorylation and subsequent activation of Gm672. Staurosporine is a potent kinase inhibitor that can prevent the phosphorylation of Gm672, thus inhibiting its functional activity. Similarly, Bisindolylmaleimide I targets Protein Kinase C, which is potentially responsible for activating Gm672. By inhibiting this kinase, Bisindolylmaleimide I can decrease the phosphorylation and activation of Gm672. LY294002 and Wortmannin both act as inhibitors of PI3K, a kinase that can be upstream in the signaling pathway of Gm672. By blocking PI3K activity, these inhibitors can lead to a reduction in the phosphorylation and activation of Gm672, thereby reducing its activity.
Moreover, PD98059 and U0126 inhibit MEK1/2 within the MAPK/ERK pathway, a pathway that can be responsible for the phosphorylation and subsequent activation of Gm672. By inhibiting MEK, these compounds can decrease the activity of Gm672. SB203580 targets p38 MAP kinase, which, if involved in the signaling pathway of Gm672, would reduce its activity through decreased phosphorylation. SP600125 inhibits JNK, and should JNK be involved in the phosphorylation of Gm672, its inhibition would result in decreased Gm672 activity. Rapamycin, an inhibitor of mTOR, can suppress the mTOR pathway possibly involved in Gm672 activation, leading to a reduction in Gm672 activity. PP2, by inhibiting Src family kinases that may phosphorylate Gm672, can lead to decreased activation and function of Gm672. Finally, Lapatinib inhibits EGFR and HER2/neu tyrosine kinases, which, if part of the signaling cascade that activates Gm672, would result in decreased activity of Gm672 through inhibition of these pathways. Each of these inhibitors targets specific kinases or pathways that are involved in the phosphorylation-based activation of Gm672, allowing for a decrease in the functional activity of the protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinases that may phosphorylate Gm672, reducing its activity by preventing its activation through phosphorylation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I specifically inhibits Protein Kinase C, which could be responsible for the activation of Gm672, thereby inhibiting its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, a kinase that could be upstream of Gm672, leading to a decrease in Gm672 activity due to reduced phosphorylation and activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, which is part of the MAPK/ERK pathway that could phosphorylate and activate Gm672, thus inhibition of MEK leads to reduced Gm672 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially reducing the phosphorylation and activation of Gm672 that is dependent on signaling through this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125 inhibits JNK, potentially reducing the activation of Gm672 if JNK is involved in its phosphorylation and subsequent activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, which could play a role in activating Gm672 through phosphorylation; thus, its inhibition leads to decreased Gm672 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2, potentially reducing the activation of Gm672 if MEK is involved in the phosphorylation pathway that activates Gm672. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which could be involved in the activation of Gm672 through kinase signaling, leading to decreased activity of Gm672. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 inhibits Src family kinases, which could phosphorylate and activate Gm672; inhibition of these kinases would lead to a decrease in Gm672 activity. |